Key Market Indicators
By 2026, Germany is projected to have 96% of persons living with HIV receiving treatment, up from 88% in 2021. This is a 1.3-point increase year-on-year. Since 2005, there has been a 2.7-point yearly growth rate in the German market. In 2021, Germany ranked 18th, with Botswana overtaking them with 88% of persons living with HIV receiving treatment. Cape Verde, Latvia and Zimbabwe were ranked 2nd, 3rd and 4th respectively. By 2026, Germany is also expected to have 223 people aged 0-14 living with HIV, up from 191 in 2021. This marks an average yearly rate of growth of 2.4%. Since 1995, the yearly growth rate in Germany has been 13.8%. In 2021, Germany was ranked 92nd, with Moldova overtaking them at 191 units. Nigeria, Mozambique and Tanzania all ranked 2nd, 3rd and 4th respectively.
